GoodRx Holdings Inc Ordinary Shares - Class A GDRX
News
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead the GoodRx Class Action Lawsuit
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoodRx Holdings, Inc. - GDRX
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against GoodRx Holdings, Inc. (GDRX)
GoodRx Announces Date for 2024 Investor Day
GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. (GDRX)
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
NASDAQ: GDRX: Kessler Topaz Meltzer & Check, LLP Files a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.
GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
GoodRx Interim CEO Extends Commitment to Company
GoodRx Reports Fourth Quarter and Full Year 2023 Results
GoodRx to Participate in Upcoming Investor Conferences